Kimberly has served in the clinical development and peri- and post-approval research groups at Evidera | PPD since 2004. Kimberly has 15 years of experience within pharmaceutical research and has spent the last 12 years dedicated to the conduct and management of peri- and post-approval research projects (both interventional and non-interventional studies). Kimberly is able to rely on her considerable experience in clinical team management and project management to oversee the delivery of full service and stand-alone studies to great effect, on time, within budget, to the highest standards of quality.
Kimberly began her career at PPD as a clinical research associate (CRA) in the PPD peri-and post-approval group. She then moved to clinical development prior to returning to the peri- and post-approval department 12 years ago. During her tenure, Kimberly has had key roles in managing many challenging studies, including a Phase IV interventional diabetes study involving 2000 sites and 6000 patients as well as a complex full service, 7-year long-term rescue study (rescued two years post study start-up) ultimately delivering an 8000-patient database, lock ready one-month prior to schedule. She has experience in a variety of therapeutic areas, including respiratory, oncology, cardiovascular, endocrinology, immunology, infectious disease, and nervous system.
Kimberly gained her Bachelor’s Degree in Chemistry from St. John Fisher College in Rochester, NY and subsequently a Master’s in Science Degree in Biochemistry from Duke University in Durham, NC.